Key result
Patients taking secondary prevention medication for acute myocardial infarction described complex personal adaptations, valuing knowledge, and how routine disruptions reduced their ability to adhere.
Why the study?
Following an acute myocardial infarction, medication adherence is poor and not fully understood, while current interventions based on presumed principles have achieved limited improvements.
What is the lived experience of taking medication for secondary prevention following an acute myocardial infarction?
What is the lived experience of taking medication for secondary prevention following an acute myocardial infarction?
Patients taking secondary prevention medications post-AMI experience complex personal adaptations, highlighting the need for patient-centered approaches to support medication adherence.
Background Following an acute myocardial infarction, patients are prescribed a regime of cardio-protective medication to prevent recurrent cardiovascular events and mortality. Adherence to medication is poor in this patient group, and not fully understood. Current interventions have made limited improvements but are based upon presumed principles. Aim To describe the phenomenon of medicine-taking for an individual taking medication for secondary prevention for an AMI. Method Interpretative Phenomenological Analysis was used to analyse transcripts of semi-structured interviews with participants. Themes were generated for each participant, then summarised across participants. Results Five key themes were produced; the participants needed to compare themselves to others, showed that knowledge of their medicines was important to them, discussed how the future was an unknown entity for them, had assimilated their medicines into their lives, and expressed how an upset to their routine reduced their ability to take medication. Conclusion Participants described complex factors and personal adaptations to taking their medication. This suggests that a patient-centred approach is appropriate for adherence work, and these themes could inform clinical practice to better support patients in their medicine adherence.
No takes yet. Share an insight, caveat, or question.
Piekarz et al. (2021) studied Acute Myocardial Infarction (n=4). Medication for secondary prevention of AMI was evaluated on Patient experience and factors influencing medicine-taking ability. Patients taking secondary prevention medication for acute myocardial infarction described complex personal adaptations, valuing knowledge, and how routine disruptions reduced their ability to adhere.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: